Eli Lilly's Diabetes Drug Is Impressive
- 235
According to Reuters, Eli Lilly's diabetes drug data is impressive to the market to the point that it hurts their rival Novo Nordisk's shares. Eli Lilly and Co said on ...
Wochit
Looking for the latest news about the stock market? Latest employment and jobs creation data? New products coming to the market? Wochit Business has the information you're looking for - when it happens.
